Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Myotilinopathy

Understanding Your Diagnosis and Pathology Report

At a Glance

Myotilinopathy (formerly LGMD1A) is diagnosed using three main tests: genetic testing for MYOT gene mutations, muscle biopsies to look for rimmed vacuoles and protein aggregates, and MRIs to check for specific patterns of fatty replacement in muscles.

Getting a definitive diagnosis for Myotilinopathy (formerly LGMD1A) is often a journey that involves three main pillars of evidence: your DNA, your muscle tissue, and medical imaging [1][2]. While genetic testing is the modern “gold standard,” doctors often use all three to be certain [3][4].

1. Genetic Testing (The DNA Blueprint)

The most definitive way to diagnose Myotilinopathy is by finding a mutation in the MYOT gene [5][1].

  • What to look for: Most patients have a “dominant missense mutation,” meaning a single change in the DNA code inherited from just one parent is enough to cause the condition [5][6].
  • Recurrent Variants: Two specific mutations—p.Ser60Phe and p.Ser55Phe—are common in Myotilinopathy families [5][6].
  • Note on Homozygosity: If your genetic report mentions “homozygosity” (two copies of the mutation), the symptoms may be more severe [6]. However, this is exceedingly rare and usually only occurs if both parents had the exact same mutation. Do not panic about having the “most severe” form unless your genetic counselor specifically confirms this.

2. Muscle Biopsy (The Cellular View)

A muscle biopsy involves taking a small sample of muscle tissue to look at under a microscope. Because Myotilinopathy is a Myofibrillar Myopathy (MFM), your pathology report will likely describe structural breakdown [5][7].

  • Rimmed Vacuoles: These are tiny “holes” or clear spaces inside the muscle fiber often surrounded by red-staining debris [8][9].
  • Protein Aggregates: These are dark clumps where the misfolded myotilin protein has bunched together [5][1].
  • Z-Disc Disarray: The report may mention that the internal structure (the Z-discs) looks “smeared” or disorganized [5][7].

3. Muscle MRI (The Visual Map)

A Muscle MRI is a non-invasive way to see which muscles are healthy and which are being replaced by fat (a process called fatty infiltration) [3][10].

  • Patterns of Involvement: In Myotilinopathy, doctors look for specific “signatures.” For example, the muscles in the back of the thigh (hamstrings) are often affected early [3].
  • Muscle Sparing: Interestingly, some muscles—like the sartorius and gracilis—often remain healthy and “spared” even when nearby muscles are weak [3]. This specific pattern helps distinguish Myotilinopathy from other types of muscular dystrophy [11][12].

Your Pathology Report Checklist

When reviewing your records with your doctor, look for these key terms:

  1. Gene: MYOT (or Myotilin) [5]
  2. Pathology: Myofibrillar myopathy, rimmed vacuoles, or protein aggregates [5][7]
  3. MRI: Fatty replacement or infiltration (especially in the thighs or calves) [3][13]
  4. Inheritance: Autosomal Dominant [5]

By combining these results, your medical team can move from a general “limb-girdle” diagnosis to a precise diagnosis of Myotilinopathy, which is essential for specialized care [3][1].

Common questions in this guide

What gene mutation causes Myotilinopathy (LGMD1A)?
Myotilinopathy is caused by a dominant missense mutation in the MYOT gene. This means a single change in the DNA code inherited from just one parent is usually enough to cause the condition.
What are 'rimmed vacuoles' on my muscle biopsy report?
Rimmed vacuoles are tiny clear spaces or holes inside the muscle fiber that are often surrounded by red-staining cellular debris. Finding these on a pathology report is a key sign of a myofibrillar myopathy like Myotilinopathy.
Why does my doctor want a muscle MRI to diagnose Myotilinopathy?
A muscle MRI non-invasively shows doctors which muscles are healthy and which are being replaced by fat. Myotilinopathy affects specific muscles, like the hamstrings, while sparing others. This unique pattern helps distinguish it from other types of muscular dystrophy.
What does 'autosomal dominant' mean on my genetic test results?
Autosomal dominant means you only need to inherit one copy of the mutated MYOT gene to develop the condition. Your genetic report will typically indicate this inheritance pattern to confirm the diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my genetic report confirm a mutation in the MYOT gene, and is it a 'dominant' variant?
  2. 2.Which specific muscles on my MRI showed the most 'fatty replacement'?
  3. 3.Do my biopsy results show 'rimmed vacuoles' or 'protein aggregates' containing myotilin?
  4. 4.If my MRI shows a certain pattern, does it match what you typically see in Myotilinopathy?
  5. 5.Can we use future MRIs to track how my muscles are changing over time?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses.

    Maerkens A, Olivé M, Schreiner A, et al.

    Acta neuropathologica communications 2016; (4()):8 doi:10.1186/s40478-016-0280-0.

    PMID: 26842778
  2. 2

    A mutation in the filamin c gene causes myofibrillar myopathy with lower motor neuron syndrome: a case report.

    Chen J, Wu J, Han C, et al.

    BMC neurology 2019; (19(1)):198 doi:10.1186/s12883-019-1410-7.

    PMID: 31421687
  3. 3

    European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A).

    Barp A, Laforet P, Bello L, et al.

    Journal of neurology 2020; (267(1)):45-56 doi:10.1007/s00415-019-09539-y.

    PMID: 31555977
  4. 4

    A novel nonsense mutation in the dimerization domain of FLNC causing mild myofibrillar myopathy.

    Park YE, Kim DS, Shin JH

    Clinical neurology and neurosurgery 2022; (221()):107386 doi:10.1016/j.clineuro.2022.107386.

    PMID: 35961230
  5. 5

    Myotilin gene duplication causing late-onset myotilinopathy.

    Spinazzi M, Savarese M, Letournel F, et al.

    European journal of neurology 2025; (32(1)):e70029 doi:10.1111/ene.70029.

    PMID: 39757377
  6. 6

    Homozygosity of the Dominant Myotilin c.179C>T (p.Ser60Phe) Mutation Causes a More Severe and Proximal Muscular Dystrophy.

    Rudolf G, Suominen T, Penttilä S, et al.

    Journal of neuromuscular diseases 2016; (3(2)):275-281 doi:10.3233/JND-150143.

    PMID: 27854214
  7. 7

    Myofibrillar and distal myopathies.

    Palmio J, Udd B

    Revue neurologique 2016; (172(10)):587-593 doi:10.1016/j.neurol.2016.07.019.

    PMID: 27638134
  8. 8

    Myopathy With SQSTM1 and TIA1 Variants: Clinical and Pathological Features.

    Niu Z, Pontifex CS, Berini S, et al.

    Frontiers in neurology 2018; (9()):147 doi:10.3389/fneur.2018.00147.

    PMID: 29599744
  9. 9

    Novel compound heterozygous mutations in the TTN gene: elongation and truncation variants causing limb-girdle muscular dystrophy type 2J in a Han Chinese family.

    Wang G, Lv X, Xu L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(5)):3427-3433 doi:10.1007/s10072-022-05979-z.

    PMID: 35239051
  10. 10

    Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints.

    Murphy AP, Morrow J, Dahlqvist JR, et al.

    Annals of clinical and translational neurology 2019; (6(6)):1033-1045 doi:10.1002/acn3.774.

    PMID: 31211167
  11. 11

    Value of muscle magnetic resonance imaging in the differential diagnosis of muscular dystrophies related to the dystrophin-glycoprotein complex.

    Xie Z, Xie Z, Yu M, et al.

    Orphanet journal of rare diseases 2019; (14(1)):250 doi:10.1186/s13023-019-1242-y.

    PMID: 31747956
  12. 12

    New genotype-phenotype correlations and transcriptomic findings in limb-girdle muscular dystrophy R9.

    Yuan Q, Xie Z, Lu Y, et al.

    Journal of neurology 2025; (272(8)):516 doi:10.1007/s00415-025-13252-4.

    PMID: 40676230
  13. 13

    Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A>G in the FKRP Gene.

    Xie Z, Xiao J, Zheng Y, et al.

    BioMed research international 2018; (2018()):3710814 doi:10.1155/2018/3710814.

    PMID: 30003095

This page explains Myotilinopathy and LGMD1A diagnostic terminology for educational purposes only. Always consult your neurologist or genetic counselor to interpret your specific test results.

Get notified when new evidence is published on Autosomal dominant limb-girdle muscular dystrophy type 1A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.